Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
申请人:Biota Scientific Management Pty Ltd.
公开号:US09163029B2
公开(公告)日:2015-10-20
The present invention relates to compounds of formula (I)
its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.
本发明涉及式(I)的化合物及其盐、异构体或前药,其在治疗病毒感染,特别是呼吸道合胞病毒(RSV)感染中具有用途。本发明还涉及制备该化合物的过程以及用于制备它们的中间体。